Form 4 for LGND LIGAND PHARMACEUTICALS INC
Accepted 2025-12-08 00:00:00 ET · period of report 2025-12-04 · accession 0002001011-25-000121 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-08 | 2025-12-04 | LGND | Davis Todd C | CEO, Dir | G - Gift | $0.00 | -130 | 161.3K | -0.1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-04 | G | D | 130 | $0.00 | 161,337 | D | — | — | (F1) Represents a bona fide gift of shares to a charitable entity. |